Coupled with the finding that KDM4B also regulates KDM3A expression and that KDM3A regulates both KDM4B and FOXA1 deposition at ER cis-regulatory sites, our data suggests a potential co-regulatory relationship between all three proteins to facilitate a cancer phenotype in ER-positive BC. The gene discussed is KDM4B; the disease is breast cancer.